Figure 2.CTSL2 expression of patients with lung adenocarcinoma grouped by (A) age, (B) gender, (C) stage, (D) vital status, (E) T classification, (F) N classification, (G) M classification, and (H) residual tumor.
Figure 2 — High CTSL2 expression predicts poor prognosis in patients with lung adenocarcinoma | Aging
